The rapid identification of MYD88 L265P and CD79B Y196 mutations can be helpful not only for the accurate molecular diagnosis of PCNSL but also for the prediction of response to R‐MPV. This evidence concerns the gene MYD88 and primary central nervous system lymphoma.